Stories about Scotland
- more
ThomasLloyd Global Asset Management GmbH
ThomasLloyd appoints Vivienne Maclachlan as Group Chief Financial Officer
moreAston Martin Lagonda of Europe GmbH
Aston Martin reveals exclusive DBX Bowmore Edition
moreAston Martin Lagonda of Europe GmbH
Bowmore and Aston Martin unveil first collaboration
One documentmoreEurofins Digital Testing Expands Cyber Security Portfolio With Acquisition of Commissum
moreTauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
moreAtlas Hotels Selects Saba to Enable Unified Talent Strategy
moreBrenntag strengthens position in the UK by acquiring specialty and industrial chemical company Tan International
moreTo support the sponsorship and mark the moment, Talisker hosted a series of events ahead of the race including a Parley Ocean School for rowers, and a gathering of like-minded outdoor adventurers, explorers, rowers and ocean enthusiasts including Brit...
moreInstitute for Advanced Sustainability Studies e.V. (IASS)
Recommendations for Responding to the Fridays for Future Movement
moreAston Martin Lagonda of Europe GmbH
Aston Martin partners with Bowmore on exclusive limited-edition whisky bottlings and innovative lifestyle experiences
One documentmoreInfosys Receives Five Awards at the DevOps Industry Awards 2019
morePenta Hotels takes part in World Cleanup Day to support their local communities in cleaning up neighbourhoods
moreGlobal Renewables Shipbrokers secures largest procurement contract for offshore wind farm in Taiwan since company establishment
moreKyowa Kirin Announces POTELIGEO® Receives Marketing Authorisation in Europe for the Treatment of Mycosis Fungoides and Sézary Syndrome
moreInnovative concepts sought: International experts discussed the digitization in higher education at Jacobs University
moreKyowa Kirin Presents Data at EORTC-Cutaneous Lymphoma Task Force Meeting Showing Significantly Improved Quality of Life for Patients With Mycosis Fungoides (MF) and Sézary Syndrome (SS) on Mogamulizumab
moreKyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome
more
1